血液学分析装置・試薬市場：製品・サービス別、価格帯別、エンドユーザー別-2025-2030年の世界予測

血液学分析装置・試薬市場は、2023年に85億8,000万米ドルと評価され、2024年には93億7,000万米ドルに達すると予測され、CAGR 8.89％で成長し、2030年には155億9,000万米ドルに達すると予測されています。

血液分析装置と試薬は、貧血、感染症、血友病、血液がんなどの病気の診断に役立つ、血液サンプルの自動分析に医療検査室で使用される重要なツールです。これらの機器は血液成分の形態学的および細胞化学的特性を測定し、臨床医が正確な診断を下すために極めて重要です。血液分析装置の必要性は、血液関連疾患の増加、老人人口の増加、早期かつ正確な診断の必要性から生じています。血液分析装置は病院、診断検査室、研究機関で使用され、臨床医、研究者、病理学者などのエンドユーザーにサービスを提供しています。市場の成長は、ポイントオブケア検査の開拓やデジタルヘルス技術との統合といった技術の進歩に加え、ヘルスケア支出の増加や診断ミスの減少に向けた世界の取り組みによってプラスの影響を受けています。しかし、高度な機器の高コスト、厳しい規制、熟練した検査技師の不足といった制約が依然として大きな課題となっています。

成長の機会は、ヘルスケア・インフラへの投資が増加している新興市場や、資源が限られた環境に適したポータブルで使いやすい機器などの製品イノベーションにあります。企業はデジタル・プラットフォームを活用してデータ管理を強化し、AIを採用してより正確な診断洞察を得ることができます。こうした機会を捉えるために、企業は費用対効果の高いソリューションの研究開発や、十分なサービスを受けていない地域の政府やNGOとの提携に注力すべきです。逆に、代替診断技術との競合は市場シェアを制限する可能性があります。小型化、接続性、自動化の統合における革新と患者中心のアプローチは、事業成長の有望分野です。血液分析装置と試薬市場は、より統合され技術的に進んだ状態へと進化しており、利害関係者は競争力を維持するために技術の進歩と市場力学に迅速に適応する必要があります。

市場力学：急速に進化する血液学分析装置・試薬市場の主要市場インサイトを公開

血液学分析装置・試薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血液疾患の高い普及率
  • 遺伝子治療、幹細胞研究、薬理ゲノミクス、ヘモグロビン異常症の分野における最近の動向
  • 診断ラボチェーンの統合の進展
• 市場抑制要因
  • 赤血球形態に関するコメント作成の制限
• 市場機会
  • 自動血球計数装置への嗜好の高まり
  • 血液学検査分野における研究開発投資と取り組みの増加
• 市場の課題
  • 安全性への懸念と製品リコール

ポーターの5つの力：血液学分析装置・試薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液学分析装置・試薬市場における外部からの影響の把握

外部マクロ環境要因は、血液学分析装置・試薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液学分析装置・試薬市場における競合情勢の把握

血液学分析装置・試薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液学分析装置・試薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液学分析装置・試薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液学分析装置・試薬市場における成功への道筋を描く

血液学分析装置・試薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血液疾患の有病率が高い
    • 遺伝子治療、幹細胞調査、薬理ゲノム学、ヘモグロビン症の分野における最近の動向
    • 診断検査室チェーンの統合が進む
  • 抑制要因
    • 赤血球形態に関するコメント生成の限界
  • 機会
    • 自動化血液学機器への関心が高まる
    • 血液検査分野における研究開発投資と努力の増加
  • 課題
    • 安全性に関する懸念と製品リコール
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液学分析装置・試薬市場：製品・サービス別

• 機器
  • 3部構成の血液分析装置
  • 5部構成の血液分析装置
  • ポイントオブケア検査血液分析装置
• リージェント
• サービス
  • 血液学サービス
  • 止血サービス
  • 免疫血液学サービス

第7章 血液学分析装置・試薬市場：価格帯別

• ハイエンド血液分析装置
• ローエンド血液分析装置
• 中規模血液分析装置

第8章 血液学分析装置・試薬市場：エンドユーザー別

• 政府参考研究所
• 病院の検査室
• 調査・学術機関

第9章 南北アメリカの血液学分析装置・試薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血液学分析装置・試薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血液学分析装置・試薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Siemens Healthineersは、Scopio Labsと契約を締結し、フルフィールドデジタル細胞形態学技術を販売します。
  • Yourbioの血液採取装置がFDAの認可を取得。
  • 画期的なヘルスケアのイノベーションを探求するため、アイルランドのソーズに実験装置研究開発センターが設立されました。
  • メルク社、Imago BioSciences, Inc.を13億5,000万米ドルで買収へ。
  • Mindrayは、すべてのIVD製品セグメントをカバーする288のIVDR CE証明書を取得しました。
  • Beckman CoulterとScopio Labsが提携し、血液学デジタル細胞形態学プラットフォームの導入を加速します。
  • CellaVisionは、少量血液学検査室向けの完全なワークフローソリューションを開始しました。
  • ラジオメーターは、ラボでの時間を節約するためのロボットソリューションでテクニコンと提携しています。
  • Sysmex Europeは、XQ-520全自動血液分析装置を発売しました。
  • 血液銀行モードを備えたSysmex AmericaのXN-10は、残留白血球カウント用にFDA承認された自動血液分析装置です。
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• Beckman Coulter, Inc. by Danaher Corporation
• BIOBASE Group
• Bioevopeak Co., Ltd.
• Biogenix Inc. Pvt. Ltd.
• Biosystems S.A. by Ginper S.L.
• Boule Diagnostics AB
• Cellavision AB
• Chengdu Seamaty Technology Co., Ltd.
• CPC Diagnostics Pvt. Ltd.
• Diatron Medical Instruments Limited
• Drucker Diagnostics, LLC
• EDAN Instruments, Inc.
• EKF Diagnostics Holdings Plc
• ERBA Diagnostics Mannheim GmbH
• F. Hoffmann-La Roche Ltd.
• Genrui Biotech Co., Ltd.
• Getein Biotech, Inc.
• HORIBA, Ltd
• Labnics Equipment Ltd.
• Labomed Inc.
• Linear Chemicals S.L.U.
• Medtronic PLC
• Mindray Bio-Medical Electronics Co., Ltd.
• Nihon Kohden Corporation
• Nova Biomedical Corporation
• PZ Cormay S.A.
• Siemens AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare

LIST OF FIGURES

• FIGURE 1. HEMATOLOGY ANALYZERS & REAGENTS MARKET RESEARCH PROCESS
• FIGURE 2. HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HEMATOLOGY ANALYZERS & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HEMATOLOGY ANALYZERS & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEMATOLOGY ANALYZERS & REAGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEMATOLOGY ANALYZERS & REAGENTS MARKET DYNAMICS
• TABLE 7. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY 3 PART HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY 5 PART HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY POINT-OF-CARE TESTING HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY REGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY HEMATOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY HEMOSTASIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY IMMUNOHEMATOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY HIGH-END HEMATOLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY LOW-END HEMATOLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY MID-RANGE HEMATOLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM HEMATOLOGY ANALYZERS & REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. HEMATOLOGY ANALYZERS & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. HEMATOLOGY ANALYZERS & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Hematology Analyzers & Reagents Market was valued at USD 8.58 billion in 2023, expected to reach USD 9.37 billion in 2024, and is projected to grow at a CAGR of 8.89%, to USD 15.59 billion by 2030.

Hematology analyzers and reagents are critical tools used in medical laboratories for the automated analysis of blood samples, aiding in diagnosing diseases like anemia, infections, hemophilia, and blood cancers. These instruments measure morphological and cytochemical characteristics of blood components, crucial for clinicians to make accurate diagnoses. The necessity for hematology analyzers arises from the increasing burden of blood-related disorders, a growing geriatric population, and the need for early and precise diagnostics. They find application in hospitals, diagnostic laboratories, and research institutes, serving end-users like clinicians, researchers, and pathologists. The market's growth is positively influenced by advancements in technology, such as the development of point-of-care testing and integration with digital health technologies, along with increased healthcare expenditures and a global focus on reducing diagnostic errors. However, constraints such as high costs of sophisticated equipment, stringent regulations, and a shortage of skilled laboratory personnel remain significant challenges.

Opportunities for growth lie in emerging markets, which are seeing an uptick in healthcare infrastructure investment, and in product innovations like portable and user-friendly devices suited for resource-limited settings. Companies can leverage digital platforms for enhanced data management and adopt AI for more precise diagnostic insights. To capture these opportunities, firms should focus on R&D for cost-effective solutions and partnerships with governments and NGOs in under-served regions. Conversely, competition from alternative diagnostic technologies can limit market share. Innovations in miniaturization, connectivity, and integration of automation, with a patient-centric approach, are promising areas for business growth. The hematology analyzers and reagents market is evolving towards a more integrated and technologically advanced state, requiring stakeholders to adapt swiftly to technological progress and market dynamics to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hematology Analyzers & Reagents Market

The Hematology Analyzers & Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of blood disorders
  • Recent developments in areas of genetic therapies, stem cell research, pharmacogenomics, and hemoglobinopathies
  • Growing consolidation of diagnostic laboratory chains
• Market Restraints
  • Limitation in generation of comments on red cell morphology
• Market Opportunities
  • Preferences rising for automated hematology instruments
  • Rising R&D investment and efforts in field of hematology testing
• Market Challenges
  • Safety concerns and product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Hematology Analyzers & Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hematology Analyzers & Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hematology Analyzers & Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hematology Analyzers & Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hematology Analyzers & Reagents Market

A detailed market share analysis in the Hematology Analyzers & Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hematology Analyzers & Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hematology Analyzers & Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hematology Analyzers & Reagents Market

A strategic analysis of the Hematology Analyzers & Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hematology Analyzers & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, BIOBASE Group, Bioevopeak Co., Ltd., Biogenix Inc. Pvt. Ltd., Biosystems S.A. by Ginper S.L., Boule Diagnostics AB, Cellavision AB, Chengdu Seamaty Technology Co., Ltd., CPC Diagnostics Pvt. Ltd., Diatron Medical Instruments Limited, Drucker Diagnostics, LLC, EDAN Instruments, Inc., EKF Diagnostics Holdings Plc, ERBA Diagnostics Mannheim GmbH, F. Hoffmann-La Roche Ltd., Genrui Biotech Co., Ltd., Getein Biotech, Inc., HORIBA, Ltd, Labnics Equipment Ltd., Labomed Inc., Linear Chemicals S.L.U., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Nova Biomedical Corporation, PZ Cormay S.A., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Hematology Analyzers & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Instrument, Regents, and Services. The Instrument is further studied across 3 Part Hematology Analyzer, 5 Part Hematology Analyzer, and Point-of-care Testing Hematology Analyzer. The Services is further studied across Hematology Services, Hemostasis Services, and Immunohematology Services.
• Based on Price Range, market is studied across High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers.
• Based on End-User, market is studied across Government Reference Laboratories, Hospital Laboratories, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of blood disorders
    • 5.1.1.2. Recent developments in areas of genetic therapies, stem cell research, pharmacogenomics, and hemoglobinopathies
    • 5.1.1.3. Growing consolidation of diagnostic laboratory chains
  • 5.1.2. Restraints
    • 5.1.2.1. Limitation in generation of comments on red cell morphology
  • 5.1.3. Opportunities
    • 5.1.3.1. Preferences rising for automated hematology instruments
    • 5.1.3.2. Rising R&D investment and efforts in field of hematology testing
  • 5.1.4. Challenges
    • 5.1.4.1. Safety concerns and product recalls
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hematology Analyzers & Reagents Market, by Product & Service

• 6.1. Introduction
• 6.2. Instrument
  • 6.2.1. 3 Part Hematology Analyzer
  • 6.2.2. 5 Part Hematology Analyzer
  • 6.2.3. Point-of-care Testing Hematology Analyzer
• 6.3. Regents
• 6.4. Services
  • 6.4.1. Hematology Services
  • 6.4.2. Hemostasis Services
  • 6.4.3. Immunohematology Services

7. Hematology Analyzers & Reagents Market, by Price Range

• 7.1. Introduction
• 7.2. High-End Hematology Analyzers
• 7.3. Low-End Hematology Analyzers
• 7.4. Mid-Range Hematology Analyzers

8. Hematology Analyzers & Reagents Market, by End-User

• 8.1. Introduction
• 8.2. Government Reference Laboratories
• 8.3. Hospital Laboratories
• 8.4. Research & Academic Institutes

9. Americas Hematology Analyzers & Reagents Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hematology Analyzers & Reagents Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hematology Analyzers & Reagents Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology.
  • 12.3.2. Yourbio Blood Collection Device Secures Fda Clearance.
  • 12.3.3. Laboratory Equipment Research & Development Centre Launched In Swords, Ireland To Explore Breakthrough Healthcare Innovations.
  • 12.3.4. Merck to Acquire Imago BioSciences, Inc. for USD 1.35 Billion.
  • 12.3.5. Mindray Takes Home 288 IVDR CE Certificates to Cover All IVD Product Segments.
  • 12.3.6. Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform.
  • 12.3.7. CellaVision Launched A Complete Workflow Solution For Low-Volume Hematology Laboratories.
  • 12.3.8. Radiometer partners with Technicon on a robotic solution to free up time in the lab.
  • 12.3.9. Sysmex Europe Launched the XQ-520 Fully Automated Haematology Analyser.
  • 12.3.10. Sysmex America's XN-10 with Blood Bank Mode is the Automated Hematology Analyzer to be FDA-Cleared for residual WBC counting.
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Beckman Coulter, Inc. by Danaher Corporation
• 4. BIOBASE Group
• 5. Bioevopeak Co., Ltd.
• 6. Biogenix Inc. Pvt. Ltd.
• 7. Biosystems S.A. by Ginper S.L.
• 8. Boule Diagnostics AB
• 9. Cellavision AB
• 10. Chengdu Seamaty Technology Co., Ltd.
• 11. CPC Diagnostics Pvt. Ltd.
• 12. Diatron Medical Instruments Limited
• 13. Drucker Diagnostics, LLC
• 14. EDAN Instruments, Inc.
• 15. EKF Diagnostics Holdings Plc
• 16. ERBA Diagnostics Mannheim GmbH
• 17. F. Hoffmann-La Roche Ltd.
• 18. Genrui Biotech Co., Ltd.
• 19. Getein Biotech, Inc.
• 20. HORIBA, Ltd
• 21. Labnics Equipment Ltd.
• 22. Labomed Inc.
• 23. Linear Chemicals S.L.U.
• 24. Medtronic PLC
• 25. Mindray Bio-Medical Electronics Co., Ltd.
• 26. Nihon Kohden Corporation
• 27. Nova Biomedical Corporation
• 28. PZ Cormay S.A.
• 29. Siemens AG
• 30. Sysmex Corporation
• 31. Thermo Fisher Scientific Inc.
• 32. Trivitron Healthcare